Looking ahead to 2030, our model projects NTLA could trade at an average price of $81.76, with a potential range between $61.32 and $102.20. This represents a potential 475.4% return from today's ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

Intellia Therapeutics ( (NTLA)) has provided an update. On April 27, 2026, Intellia Therapeutics reported positive topline Phase 3 results from its global HAELO trial of lonvoguran ziclumeran, an in ...

Intellia Therapeutics (NTLA) recently reported positive topline results from its global Phase 3 HAELO trial of lonvoguran ziclumeran, or lonvo z, for hereditary angioedema, and has started a rolling ...

Here are Cathie Wood’s latest moves.

BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...

Big Tech earnings delivered mixed signals, with rising AI capex plans raising concerns about near-term profitability. ・Oil ...

Shares of electric vehicle and energy specialist Tesla ( TSLA +2.71%) have come roaring back. After spending most of the year ...

Tesla (NASDAQ:TSLA | TSLA Price Prediction) closed Monday at $445, capping a 13.37% weekly surge that pushed the stock back ...

Dungeons & Dragons (D&D) is an incredibly successful role-playing game. Today I introduce a new kind of D&D game. I call it Data & Doubt. There's a heck of a D&D match going on right now between ...